We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

62 hedge funds and large institutions have $106M invested in Clearside Biomedical in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 20 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 1

233% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 6

107% more funds holding

Funds holding: 30 → 62 (+32)

3.22% more ownership

Funds ownership: 0% → 3.22% (+3.2%)

23% less capital invested

Capital invested by funds: $138M → $106M (-$31.5M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
62
Holders Change
+32
Holders Change %
+106.67%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
20
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.6M
2
CAM
Cormorant Asset Management
Massachusetts
+$5.78M
3
BFA
BlackRock Fund Advisors
California
+$5.53M
4
O
OrbiMed
New York
+$5.02M
5
Millennium Management
Millennium Management
New York
+$4.88M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.71M
2
RSCM
Rock Springs Capital Management
Maryland
-$4.85M
3
TRCT
Tower Research Capital (TRC)
New York
-$111K
4
CS
Credit Suisse
Switzerland
-$92.6K
5
JP Morgan Chase
JP Morgan Chase
New York
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$20.9M +$5.78M +23,009 +17%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$14.7M -$6.71M -26,734 -20%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$9.21M +$13.6M +54,259 +377%
RSCM
4
Rock Springs Capital Management
Maryland
$8.36M -$4.85M -19,334 -24%
PA
5
Perceptive Advisors
New York
$6.37M +$1.29M +5,151 +12%
HIM
6
Hillhouse Investment Management
Cayman Islands
$5.36M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.23M +$4.25M +16,912 +76%
BFA
8
BlackRock Fund Advisors
California
$4.93M +$5.53M +22,027 +150%
Marshall Wace
9
Marshall Wace
United Kingdom
$4.02M +$4.85M +19,321 +181%
SFM
10
Sphera Funds Management
Israel
$2.68M +$1.24M +4,927 +33%
O
11
OrbiMed
New York
$2.68M +$5.02M +20,000 New
Millennium Management
12
Millennium Management
New York
$2.61M +$4.88M +19,448 New
OM
13
Opaleye Management
Massachusetts
$2.41M +$4.52M +18,000 New
LCM
14
Laurion Capital Management
New York
$1.83M +$3.42M +13,633 New
ACP
15
Acuta Capital Partners
California
$1.56M +$2.93M +11,667 New
Tudor Investment Corp
16
Tudor Investment Corp
Connecticut
$1.18M +$2.22M +8,829 New
AIC
17
AWM Investment Company
New York
$1.12M +$1.26M +5,000 +150%
NC
18
Nexthera Capital
New York
$1.08M +$2.02M +8,051 New
State Street
19
State Street
Massachusetts
$911K +$764K +3,045 +81%
First Manhattan
20
First Manhattan
New York
$894K +$1.67M +6,667 New
Northern Trust
21
Northern Trust
Illinois
$818K +$1.53M +6,103 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$811K +$814K +3,244 +116%
BIT
23
BlackRock Institutional Trust
California
$778K +$1.01M +4,042 +229%
MIM
24
Monashee Investment Management
Massachusetts
$671K +$1.26M +5,000 New
KCM
25
Kornitzer Capital Management
Kansas
$670K +$1.26M +5,000 New
1
2 3

CLSD Hedge Fund Activity: Q4 2016 in Review

62 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2016, worth a combined $106M — down 23% from $138M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new CLSD positions and 1 closed out — a net gain of 32 holders — while 20 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $13.6M. The largest seller was Wellington Management Group, cutting an estimated $6.71M.

  • 62 institutional investors held Clearside Biomedical (CLSD) as of Q4 2016, up from 30 in Q3 2016.
  • Funds reported $106M of Clearside Biomedical stock for Q4 2016, down 23% quarter-over-quarter.
  • 33 funds opened new Clearside Biomedical positions in Q4 2016 and 1 closed out, a net change of +32 holders.
  • The largest Clearside Biomedical buyer in Q4 2016 was Fidelity Investments, an estimated $13.6M added.
  • The largest Clearside Biomedical seller in Q4 2016 was Wellington Management Group, an estimated $6.71M sold.

Based on aggregated 13F filings for Q4 2016.